ABOUT AUTHOR:
Kushwaha Anjali *
Naraina vidhya pith, faculty of pharmacy,
Gangaganj, Kanpur
* anjali.kushwaha1@gmail.com

ABSTRACT
Many traditional drugs when given orally exhibit poor and/or highly variable bioavailability and are often accompanied by significant gastro-intestinal side effects. The proprietary powder processing techniques developed by Nanotherapeutics improve the delivery of drugs that cannot normally be taken orally. Nanotherapeutics has developed new inhalation, nasal, injectable, and oral particle delivery systems that:

• Improve the safety and efficacy of low molecular weight drugs,
• Improve the stability and absorption of proteins that normally cannot be taken orally, and
• Extend the life cycle of many existing drug formulations.

Franco-Indian Pharmaceuticals Pvt. Ltd., a name that stands for quality and innovation, is one of the major players in the Pharmaceutical Industry in India.
 Our innovative, value added products improve the quality of life of people and ease their sufferings and help them to enjoy, longer, healthier and more productive lives.

Govt. of Haryana has set up a new Medical College at Khanpur Kalan in District Sonepat. It is a Govt. College for girls. Posts of ancillary services are lying vacant on regular basis in BPS Government Medical College for Women, Khanpur Kalan, Sonepat. Applications on the prescribed form are invited for the following posts of ancillary services:-

The GREEN ROYAL ACADEMY OF PHARMACEUTICAL EDUCATIONAL SOCIETY College of Pharmacy is the premier Educational Institute promoted by the Ramachandra Educational Society, which was established in May 2009 with best education particularly in pharmacy education in and around Ponguturu.

Post: Lecturer, Assistant Professor

Applications with a photograph uploaded are invited on-line only exclusively from qualified Physically Handicapped candidates of Kerala State for filling the backlog vacancies earmarked for the period from 1.1.2004 to 31.12.2007 and identified by the Govt. vide GO(P) No.7/2011/SWD dated 24.1.2011 for selection to the under mentioned post.

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr. McCarrison as its first Director. It was shifted to Hyderabad in 1958.

Bengal Chemical & Pharmaceutical Works Ltd.(BCPW)  is precursor of the present Company, Bengal Chemicals & Pharmaceuticals Ltd (BCPL).  Acharya P C Ray  took a rented house at 91 Upper Circular Road, Calcutta and started business with a meager capital of Rs 700.00. Since inception of the Company he was very much quality conscious and produced various products of British Pharmacopoeia standard.

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram is an Institute of National Importance  established by an Act  of the Indian Parliament  and  under the 2 administrative control of the Department of Science and Technology, Government of India.

Manali Petrochemicals Limited (MPL) is an India leader in the production and marketing of propylene oxide, propylene glycols and polyols that find widespread application in the pharmaceutical, food, fragrance, automobile, garments, refrigeration and the oil & gas industries. MPL's turnover for FY 2011 was INR 4530 million.

About Authors:
^*1P.SanilKumar, ¹C K. Dhanapal, ²Sandhya Ravi
¹Department of Pharmacy,
Annamali University, AnnamaliNager,
Chidambaram, Tamilnadu.
²Lotus Labs Pvt Ltd,
No.07, Jasmabhavan Road, Vasanthanager, Bangalore, Karnataka.
*sanilmpharm@gmail.com

ABSTRACT
Hospitals are created for cure the disease but not for the spreading of diseases, even though this statement is true to the theoretical concept but it is not possible practically due to various risk factors. The spread of infection in the hospitals occurs due to the microorganism. Nosocomial infections add significantly to the economic burden of managing the underlying disease that has lead to hospitalization of the patient. More than 90% of reported infections are bacterial where as viral, fungal or protozoal infections are less commonly involved in hospital-acquired infections. This project deals with bacterial nosocomial pathogens only, since they are by far major causes of nosocomial infections. Objective of the present study include  the identification, prevention and control of nosocomial infection in our hospitals. The ultimate aim is the reduction of nosocomial infections and their costs. Baseline study for morbidity pattern in the hospitals, finding sources of exogenous and endogenous sources of nosocomial infection. Suggest measures to minimize the nosocomial infections and suggest guidelines for efficacious management of nosocomial infections.

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Micro therapeutic Research Labs (MTR) is a quality driven, full service oriented Clinical Research Organization (CRO) that provides a broad range of clinical research services to the global pharmaceutical and biotechnology industry.
Situated in three different locations namely Selaiyur, Coimbatore and Padi in Tamilnadu, the southern part of India; Micro Therapeutic Research Labs offers you world-class services that are truly customized for your unique research requirements.

Shasun Pharmaceutical Division develops and manufactures formulations for solid dosage products. Shasun Pharmaceutical Division develops and manufactures formulations for solid dosage products. The Division is a vertically integrated formulations partner for the pharmaceutical industry.

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.